APA (7th ed.) Citation

V, P., MM, B., JM, K., G, M., RT, C., JW, Y., . . . Team, U. V. A. E. R. S. (2002). Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps-rubella vaccine in the United States. Pediatrics, 110(6), 9p. https://doi.org/10.1542/peds.110.6.e71

Chicago Style (17th ed.) Citation

V, Pool, Braun MM, Kelso JM, Mootrey G, Chen RT, Yunginger JW, Jacobson RM, Gargiullo PM, and US Vaccine Adverse Event Reporting System Team. "Prevalence of Anti-gelatin IgE Antibodies in People with Anaphylaxis After Measles-mumps-rubella Vaccine in the United States." Pediatrics 110, no. 6 (2002): 9p. https://doi.org/10.1542/peds.110.6.e71.

MLA (9th ed.) Citation

V, Pool, et al. "Prevalence of Anti-gelatin IgE Antibodies in People with Anaphylaxis After Measles-mumps-rubella Vaccine in the United States." Pediatrics, vol. 110, no. 6, 2002, p. 9p, https://doi.org/10.1542/peds.110.6.e71.